NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive ...
Read MoreThe “ Cities of Possibility: The Evolution of Quality of Life in Saudi Arabia” report reveals how a focus on quality of life has enhanced citizen well-being. From lifestyle and recreation to opportunity and social growth, measurements from ...
Read MoreNursing students are not only learning procedures and protocols; they are actively developing the ability to notice subtle changes, prioritize under pressure, and choose the safest next step for each patient. Clinical judgment is what gradually ...
Read MoreNursing education continues to evolve rapidly as healthcare systems worldwide grow more complex and technologically advanced. From clinical reasoning to evidence-based practice and patient-centered care, nursing students are expected to master a ...
Read MoreDecember 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVue TM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1 TM -FFR, ...
Read MoreBRISBANE, Australia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Byron Medical is excited to announce their exclusive distribution of BlancOne, a system developed with cutting-edge photochemistry and biophotonics that is rewriting the rules of ...
Read MoreSPRING, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data ...
Read MorePR Newswire INDIANAPOLIS, Dec. 12, 2025 As monotherapy, imlunestrant demonstrated an 11.4-month numeric improvement in median OS versus endocrine therapy in patients with ESR1-mutated disease In all patients, the imlunestrant plus ...
Read MorePR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune ...
Read MorePR Newswire VANCOUVER, BC, Dec. 12, 2025 ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion ...
Read MorePR Newswire BOSTON, Dec. 12, 2025 New landmark partnership with Cartwheel, The Brookline Center for Community Mental Health (BCCMH), and Boston Public Schools ensures timely, multilingual mental health services for students, families, ...
Read MorePR Newswire NEW YORK, Dec. 12, 2025 - ATNM-400's target antigen is overexpressed in breast cancer and its expression is further increased in breast cancer cells resistant to standard of care endocrine therapy, tamoxifen and the HER2 ...
Read MorePR Newswire NANTONG, China, Dec. 12, 2025 NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in ...
Read MorePR Newswire FORT LAUDERDALE, Fla., Dec. 12, 2025 LifeBridge's Lung Immunity Support Is a Tool for Respiratory Health During a Busy Holiday Season FORT LAUDERDALE, Fla., Dec. 12, 2025 /PRNewswire/ -- New report finds the flu season could ...
Read MorePR Newswire NANTONG, China, Dec. 12, 2025 NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in ...
Read MorePR Newswire HONG KONG, Dec. 12, 2025 HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced ...
Read MorePR Newswire CAMBRIDGE, Mass., Dec. 12, 2025 CAMBRIDGE, Mass., Dec. 12, 2025 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a ...
Read MorePR Newswire CAMBRIDGE, Mass., Dec. 12, 2025 CAMBRIDGE, Mass., Dec. 12, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapy for oncology and inflammation & immunology ...
Read MorePR Newswire HYDERABAD, India, Dec. 12, 2025 As part of its social impact commitment, Apex CoVantage is supporting 1,000 cataract surgeries with LVPEI to improve access to vision care for disadvantaged communities. HYDERABAD, India, Dec. ...
Read MorePR Newswire BILLINGSHURST, England, Dec. 12, 2025 BILLINGSHURST, England, Dec. 12, 2025 /PRNewswire/ -- More than 123 million people worldwide were forcibly displaced by the end of 2024 – the highest number ever recorded – according to the ...
Read MorePR Newswire GUWAHATI, India, Dec. 12, 2025 Performs the region's first-ever combined TAVI and Angioplasty on a high-risk patient GUWAHATI, India, Dec. 12, 2025 /PRNewswire/ -- Apollo Excelcare Hospital, Guwahati, has achieved a major ...
Read MorePR Newswire HONG KONG, Dec. 11, 2025 HONG KONG, Dec. 11, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric ...
Read MorePR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 11, 2025 SAN FRANCISCO and SUZHOU, China, Dec. 11, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
Read MorePR Newswire JACKSONVILLE, Fla., Dec. 11, 2025 JACKSONVILLE, Fla., Dec. 11, 2025 /PRNewswire/ -- A new study published today in The Lancet showed results from the largest of its kind Phase III trial demonstrating a significant survival ...
Read MorePR Newswire THOUSAND OAKS, Calif., Dec. 11, 2025 UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK Ab+ gMG THOUSAND ...
Read MorePR Newswire SAN JOSE, Calif., Dec. 11, 2025 Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the vaccine generated T ...
Read MorePR Newswire ROCKVILLE, Md., Dec. 11, 2025 ASHA Offers Safe Listening Guidance for Families ROCKVILLE, Md., Dec. 11, 2025 /PRNewswire-PRWeb/ -- If you're shopping for a tween or teen this holiday season, chances are they have at least one ...
Read MorePR Newswire COSTA MESA, Calif., Dec. 11, 2025 COSTA MESA, Calif., Dec. 11, 2025 /PRNewswire/ -- The authoritative neuroradiology reference Diagnostic Imaging: Brain, Fifth Edition (Elsevier) now confirms that functional neuroimaging tools ...
Read MorePR Newswire HUNTINGTON STATION, N.Y., Dec. 11, 2025 UBCF's November Pink Bag Shopping event provided essential support and holiday-season relief to 91 women managing the impacts of breast cancer HUNTINGTON STATION, N.Y., Dec. 11, 2025 ...
Read MorePR Newswire KENOSHA, Wis., Dec. 11, 2025 Kenosha-based center offering complimentary mental health treatments for firefighters KENOSHA, Wis., Dec. 11, 2025 /PRNewswire/ -- Empower Mental Health & Wellness Clinic is offering complimentary ...
Read MorePR Newswire EDINBURGH, Scotland, Dec. 11, 2025 EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new ...
Read More
MEDINDIA
English
हिन्दी
Español
français
中文